Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses

Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins…

Ceva Animal Health has renamed Tildren, its tiludronate-based bisphosphonate infusion for the treatment of bone spavin in horses, as Equidronate.

Tiludronate has been used to treat bone spavin and navicular disease in Europe for many years and was licensed…

Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.

Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and…

Norbrook Laboratories has launched powder and paste versions of Noroquin - its glucosamine-based supplement range - for horses.

Noroquin contains the active ingredients glucosamine, chondrotin sulphate, manganese sulphate, zinc sulphate, absorbic acid…

Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.

Flexi4 contains…

Vétoquinol has announced the return of Navilox powder (isoxsuprine hydrochloride), the only medication specifically licensed in the UK for use in cases of navicular disease in horses.

Navicular disease is a chronic degenerative condition of the…

Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.

Dechra…

Imprint has announced the launch of graphite-coloured Hoof Repair - a low melt mouldable thermoplastic product used for the repair of cracked and damaged hooves which colour matches the natural hoof for improved aesthetics.

Hand-mouldable into any shape…

Cavalor has announced the launch of ArtiTec, an anti-inflammatory joint supplement for horses and ponies that have suffered a joint trauma, which the company says is proven effective in a good quality controlled trial¹.

In the trial, published in the…

Boehringer Ingelheim has rebranded its equine joint supplement, Seraquin GLME, as Equitop GLME.

Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments…

Boehringer Ingelheim Animal Health has announced the launch of Arti-Cell Forte, the first stem cell-based veterinary medicine to get marketing authorisation for treating equine lameness, calling it a 'breakthrough medicine for degenerative joint disease…

Boehringer Ingelheim has received UK marketing authorisation for RenuTend - the first licensed treatment to improve healing of tendon injuries and suspensory ligaments in horses.

Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says…